Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: Azithromycin versus ceftibuten

Chemotherapy

Volumn 42, Issue 3, 1996, Pages 231-234

  Galova, K ^a   Sufliarska, S ^c   Kukovac, Z ^c   Danisovicova, A ^b   Hrachova, I ^b   Grausova, S ^d   Marinova, I ^a   Krizan, S ^d   Stopkova, K ^d   Stahorska, A ^d   Durcanska, K ^b   Raskova, J ^c   Krupova, I ^d   Krcmery V ^d  

^a Children's Hospital   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c Physics and Informatics   (Slovakia)

^d TRNAVA UNIVERSITY   (Slovakia)

Author keywords

Azithromycin; Ceftibuten; Infections Once daily regimens; Pediatric respiratory tract

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTIBUTEN;

ADOLESCENT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERANCE; EOSINOPHILIA; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PEDIATRICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 0029867069     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239448     Document Type: Article

References (6)

1. Mikolajova M: Cefuroxims axctil in initial management of pediatric bronchopneumonia. Med Pregi 1994:50:55.
2. Schmitzburger R, Guggcnbichler JP: Pneumonia in pediatrics: Differences in clinical features, radiology among different pathogens. Antibiot Monitor 1990;6:53.
3. Bergan T, Jorgensen NP: Azithromycin pharmacokinetics and penetration. Scand J Infect Dis Suppl 1992:83:15.
4. Krcmery S, Tomasik E: Changing etiology and current problems of ATB therapy in Slovak hospitals. Med Rev 1994:50:33.
5. Jones RN: Ceftibuten: A review of antimicrobial activity. Pediatr Infect Dis J 1993:12:37
6. Meclin S, McCarty JM, Pichichero ME: Multiccnter controlled trial comparing ceftibuten and amoxycil-linclavulanate in the empiric therapy of acute otitis media. Pediatr Infect DisJ 1993:12:70.